Notice of Effectiveness (effect)
26 Dicembre 2018 - 12:02PM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
December 21,
2018
|
|
Accession Number:
|
0001193125-18-348308
|
|
Submission Type:
|
POS AM
|
|
CIK:
|
0001114220
|
|
Company Name:
|
KERYX BIOPHARMACEUTICALS INC
|
|
File Number:
|
333-190353
|
Grafico Azioni Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Storico
Da Mag 2023 a Mag 2024
Notizie in Tempo Reale relative a Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ): 0 articoli recenti
Più Keryx Biopharmaceuticals Inc Articoli Notizie